A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy-Reference-Cited by-同舟云学术

A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy

Published:2018-03-20 Issue:10 Volume:45 Page:1731-1741
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Manceau Vincent,Palard Xavier,Rolland Yan,Pracht March,Le Sourd Samuel,Laffont Sophie,Boudjema Karim,Lievre Astride,Mesbah Habiba,Haumont Laure-Anne,Lenoir Laurence,Brun Vanessa,Uguen Thomas,Edeline Julien,Garin Etienne^ORCID

Funder

Ligue Contre le Cancer

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-018-3990-7/fulltext.html

Reference33 articles.

1. Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet Lond Engl. 2014;383(9935):2168–79.

2. Bridgewater J, Galle PR, Khan SA, Llovet JM, Park J-W, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268–89.

3. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136(4):1134–44.